Kemp Kernstine
Overview
Explore the profile of Kemp Kernstine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
2088
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Travis W, Eisele M, Nishimura K, Aly R, Bertoglio P, Chou T, et al.
J Thorac Oncol
. 2024 Mar;
19(7):1028-1051.
PMID: 38508515
Introduction: Spread through air spaces (STAS) consists of lung cancer tumor cells that are identified beyond the edge of the main tumor in the surrounding alveolar parenchyma. It has been...
2.
Huang J, Osarogiagbon R, Giroux D, Nishimura K, Bille A, Cardillo G, et al.
J Thorac Oncol
. 2023 Oct;
19(5):766-785.
PMID: 37866624
Introduction: The accurate assessment of nodal (N) status is crucial to the management and prognostication of nonmetastatic NSCLC. We sought to determine whether the current N descriptors should be maintained...
3.
He X, Yin S, Liu H, Lu R, Kernstine K, Gerber D, et al.
Front Surg
. 2021 Nov;
8:649531.
PMID: 34722619
Current treatment guidelines for stage IV non-small cell lung cancer (NSCLC) with brain metastases recommend brain treatments, including surgical resection and radiotherapy (RT), in addition to resection of the primary...
4.
Li B, Yang Y, Toker A, Yu B, Kang C, Abbas G, et al.
J Thorac Dis
. 2021 Jan;
12(12):7387-7401.
PMID: 33447428
No abstract available.
5.
Gong K, Guo G, Panchani N, Bender M, Gerber D, Minna J, et al.
Nat Cancer
. 2020 Dec;
1(4):394-409.
PMID: 33269343
EGFR inhibition is an effective treatment in the minority of non-small cell lung cancer (NSCLC) cases harboring EGFR-activating mutations, but not in EGFR wild type (EGFRwt) tumors. Here, we demonstrate...
6.
Heid C, Lopez V, Kernstine K
Dis Esophagus
. 2020 Nov;
33(Supplement_2).
PMID: 33241303
Advances in minimally invasive techniques, including robotic surgical technology, have led to improved outcomes in esophagectomy. In this article, we detail our approach to the robotic Ivor Lewis esophagectomy.
7.
Maclean M, Luo X, Wang S, Kernstine K, Gerber D, Xie Y
Oncotarget
. 2018 Jun;
9(36):24470-24479.
PMID: 29849954
Introduction: The current recommendation for the treatment of stage II and III NSCLC is surgery with chemotherapy. While the convention is to administer chemotherapy postoperatively (adjuvant chemotherapy), inconsistent results have...
8.
Geoffrion T, DeKeyzer L, Shah G, Nair S, Pirolli T, Kernstine K
J Surg Case Rep
. 2018 Apr;
2018(4):rjy047.
PMID: 29644036
Paraganglioma is a rare extra-adrenal tumor of the paraganglia often found in association with sympathetic and parasympathetic nerves. The case presented is of a 10-year-old boy with hemoptysis who was...
9.
Wanat-Hawthorne A, Stubblefield J, Lynch I, Dellaria S, Kernstine K
J Cardiothorac Vasc Anesth
. 2018 Apr;
33(3):776-780.
PMID: 29631944
No abstract available.
10.
Gong K, Guo G, Gerber D, Gao B, Peyton M, Huang C, et al.
J Clin Invest
. 2018 Apr;
128(6):2500-2518.
PMID: 29613856
Although aberrant EGFR signaling is widespread in cancer, EGFR inhibition is effective only in a subset of non-small cell lung cancer (NSCLC) with EGFR activating mutations. A majority of NSCLCs...